120 related articles for article (PubMed ID: 38587194)
1. Proteolytic cleavage of the TGFβ co-receptor CD109 changes its conformation, resulting in protease inhibition via activation of its thiol ester, and dissociation from the cell membrane.
Jensen KT; Nielsen NS; Viana Almeida A; Thøgersen IB; Enghild JJ; Harwood SL
FEBS J; 2024 Apr; ():. PubMed ID: 38587194
[TBL] [Abstract][Full Text] [Related]
2. Cell Surface Processing of CD109 by Meprin β Leads to the Release of Soluble Fragments and Reduced Expression on Extracellular Vesicles.
Lückstädt W; Bub S; Koudelka T; Pavlenko E; Peters F; Somasundaram P; Becker-Pauly C; Lucius R; Zunke F; Arnold P
Front Cell Dev Biol; 2021; 9():622390. PubMed ID: 33738281
[TBL] [Abstract][Full Text] [Related]
3. The conformational change of the protease inhibitor α
Harwood SL; Diep K; Nielsen NS; Jensen KT; Enghild JJ
J Biol Chem; 2022 Aug; 298(8):102230. PubMed ID: 35787371
[TBL] [Abstract][Full Text] [Related]
4. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β.
Tanabe M; Hosokawa K; Nguyen MAT; Nakagawa N; Maruyama K; Tsuji N; Urushihara R; Espinoza L; Elbadry MI; Mohiuddin M; Katagiri T; Ono M; Fujiwara H; Chonabayashi K; Yoshida Y; Yamazaki H; Hirao A; Nakao S
Leukemia; 2022 Mar; 36(3):847-855. PubMed ID: 34743190
[TBL] [Abstract][Full Text] [Related]
5. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.
Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A
Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622
[TBL] [Abstract][Full Text] [Related]
6. CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.
Zhang JM; Murakumo Y; Hagiwara S; Jiang P; Mii S; Kalyoncu E; Saito S; Suzuki C; Sakurai Y; Numata Y; Yamamoto T; Takahashi M
Biochem Biophys Res Commun; 2015 Apr; 459(2):252-258. PubMed ID: 25724945
[TBL] [Abstract][Full Text] [Related]
7. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
[TBL] [Abstract][Full Text] [Related]
8. Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.
Hagiwara S; Murakumo Y; Mii S; Shigetomi T; Yamamoto N; Furue H; Ueda M; Takahashi M
Oncogene; 2010 Apr; 29(15):2181-91. PubMed ID: 20101215
[TBL] [Abstract][Full Text] [Related]
9. Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins.
Lin M; Sutherland DR; Horsfall W; Totty N; Yeo E; Nayar R; Wu XF; Schuh AC
Blood; 2002 Mar; 99(5):1683-91. PubMed ID: 11861284
[TBL] [Abstract][Full Text] [Related]
10. Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes.
Finnson KW; Tam BY; Liu K; Marcoux A; Lepage P; Roy S; Bizet AA; Philip A
FASEB J; 2006 Jul; 20(9):1525-7. PubMed ID: 16754747
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses.
Li C; Hancock MA; Sehgal P; Zhou S; Reinhardt DP; Philip A
Biochem J; 2016 Mar; 473(5):537-47. PubMed ID: 26621871
[TBL] [Abstract][Full Text] [Related]
12. Reaction of methylamine with human alpha 2-macroglobulin. Mechanism of inactivation.
Eccleston ED; Howard JB
J Biol Chem; 1985 Aug; 260(18):10169-76. PubMed ID: 2410421
[TBL] [Abstract][Full Text] [Related]
13. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
[TBL] [Abstract][Full Text] [Related]
14. CD109 drives pro-tumorigenic cell properties in human non-small cell lung cancer through interaction with desmoglein-2.
Lückstädt W; Rathod M; Möbus L; Bub S; Lucius R; Elsner F; Spindler V; Arnold P
Res Sq; 2024 Mar; ():. PubMed ID: 38562713
[TBL] [Abstract][Full Text] [Related]
15. Differences in the proteinase inhibition mechanism of human alpha 2-macroglobulin and pregnancy zone protein.
Jensen PE; Stigbrand T
Eur J Biochem; 1992 Dec; 210(3):1071-7. PubMed ID: 1282886
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin.
Driesbaugh KH; Buzza MS; Martin EW; Conway GD; Kao JP; Antalis TM
J Biol Chem; 2015 Feb; 290(6):3529-41. PubMed ID: 25519908
[TBL] [Abstract][Full Text] [Related]
17. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
[TBL] [Abstract][Full Text] [Related]
18. Development of selective protease inhibitors via engineering of the bait region of human α
Harwood SL; Nielsen NS; Diep K; Jensen KT; Nielsen PK; Yamamoto K; Enghild JJ
J Biol Chem; 2021 Jul; 297(1):100879. PubMed ID: 34139236
[TBL] [Abstract][Full Text] [Related]
19. α
Harwood SL; Nielsen NS; Jensen KT; Nielsen PK; Thøgersen IB; Enghild JJ
J Biol Chem; 2020 Dec; 295(49):16732-16742. PubMed ID: 32978260
[TBL] [Abstract][Full Text] [Related]
20. Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling.
Mori N; Esaki N; Shimoyama Y; Shiraki Y; Asai N; Sakai T; Nishida Y; Takahashi M; Enomoto A; Mii S
Pathol Res Pract; 2023 May; 245():154443. PubMed ID: 37030166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
